🔗 Share this article

Given that America undertakes sweeping revisions to its immunization schedules, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, an American of Danish descent sports physician and public health researcher who rose to prominence by expressing skepticism about COVID-19 vaccines during the pandemic and has concentrated on potential fatalities after COVID-19 vaccination in her recent time at the FDA.

Proposed Changes to Childhood Immunization Program

Agency leaders had intended to unveil sweeping changes to the pediatric immunization program in December, aligning the US with Denmark’s vaccine program, according to reports – a significant shift that would put the US out of alignment with many the global community with little proof for benefit. This reveal has been pushed back until the new year.

In place of the top vaccines chief, Høeg is listed to speak at the meeting. She was newly appointed acting director of the FDA’s CDER, the fifth individual to head the center this year.

Consolidating Power at the FDA

The acting appointment may indicate a strengthened alliance between the pharmaceutical and vaccine divisions as Dr. Høeg and Prasad strengthen their influence at the agency – and it points to a increased emphasis upon dismantling previously authorized immunizations at the FDA.

Høeg has frequently advocated for discontinuing specific childhood vaccine recommendations in the US in order to be more in line with Denmark, a nation with universal health coverage and a number of inhabitants about the population of the state of Wisconsin.

So far public appearances, she has kept her attention on immunizations – typically the domain of Dr. Prasad, chief of the FDA’s vaccine center – instead of medication approval.

Doubts Over Background

The appointee has no apparent track record in pharmaceutical research, approval processes or administrative roles, which has been standard for previous directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a key advisor to the commissioner and the vaccine center since spring.

“She appears not to have any of the qualifications” for running the pharmaceutical oversight division, remarked Dr. Jonathan Howard. “She has not conducted a randomized controlled trial. She is not versed in managing a major agency. She lacks background in industry regulation.”

Former heads of CBER would “be deeply familiar with laws and regulations and the science of medication creation”, said Dr. Janet Woodcock. “Clearly, she lacks the type of experience that former directors who headed the center have had.”

CDER has an vast portfolio at the FDA, Woodcock emphasized.

“The public just pays attention on the new drug program, but the generic program authorizes thousands of off-brand pharmaceuticals. There is also a biosimilars program, OTC medication office and more, and all of those must be managed,” Woodcock noted. “The area you don’t keep your eye on, that’s the thing that I always told people is going to come back to haunt you.”

Additionally, a substantial administrative element to the job, which supervises more than 5,000 personnel. “It’s a enormous leadership role, if you do it right,” Woodcock said.

Response and Controversial Programs

When asked about concerns about Dr. Høeg's credentials and whether this appointment represents greater collaboration among agency officials on vaccines, a press secretary said that the “questions rely on flawed presumptions”.

“This background is consistent with the responsibilities of her position,” the spokesperson stated, citing the period Dr. Høeg spent advising the agency head on “pharmaceutical safety and approval science, including predictive safety algorithms and shot safety tracking”.

As acting director, Dr. Høeg assumes responsibility for the commissioner’s controversial expedited review system, a contentious expedited drug-approval program that reportedly concerned her preceding directors. “By what process are these drugs being selected for this voucher program? Who is making the calls?” Dr. Howard said. “There is a lot of confidentiality occurring at the agency right now.”

Overall, he remarked, “the agency appears to be shifting towards less stringent rules of pharmaceuticals, except for immunizations.”

Public History on Vaccines

Regarding vaccines, Høeg has a more established, if concerning, history, some experts said. She released a research paper using non-validated volunteer-provided data to assess the incidence of myocarditis following Covid vaccination. She consulted for the Florida top health official Dr. Joseph Ladapo, who allegedly have modified findings to suggest Covid vaccines are pose a greater threat than they are.

Part of her “policy goals” for the current government featured changing guidelines for new vaccines and discontinuing “unnecessary” immunizations, she stated after the election on a online show. At the FDA, Dr. Høeg has allegedly proposed preventing young men from obtaining COVID-19 vaccines.

“She’s an complete ideologue who commences with her beliefs and works backwards to fit the science in a very disingenuous, fraudulent fashion,” Howard stated.

Taking Control and a “Revenge Tour”

Dr. Høeg aligned with other dissenters, {like|